Authorised EU health claim for arabinoxylan

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

1 Citation (Scopus)

Abstract

Arabinoxylans are hemicellulose dietary fibres abundant in the bran of many cereal grains including wheat and rice. They pass undigested through the human intestine until they reach the colon where they provide substrates for bacterial fermentation, generating beneficial short-chain fatty acids including acetate, butyrate and propionate. As viscous fibres, arabinoxylans help suppress appetite, delay gastric emptying and slow post-prandial glucose and insulin responses as well as promote laxation. Their beneficial effects on post-prandial glucose responses have been recognised by the European Food Safety Authority, and the European Union has authorised a health claim that 'consumption of arabinoxylan as part of a meal contributes to a reduction of the blood glucose rise after that meal'. Eight substantiating research trials are reviewed, four in healthy adults, three in people with metabolic disturbance and one in people with type 2 diabetes. Results indicate that arabinoxylans added to foods have particular utility for people with disturbed metabolic responses or type 2 diabetes to support improved cardiovascular health.

Original languageEnglish
Title of host publicationFoods, Nutrients and Food Ingredients with Authorised EU Health Claims
EditorsMichelle Sadler
Place of PublicationUnited Kingdom
PublisherElsevier
Chapter13
Pages201-218
Number of pages18
Volume3
ISBN (Electronic)9780081010068
ISBN (Print)9780081009222
DOIs
Publication statusPublished - 2018

Keywords

  • Arabinoxylans
  • Diabetes
  • Dietary fibre
  • Metabolic syndrome
  • Post-prandial glucose

Cite this

Kellow, N. J., & Walker, K. Z. (2018). Authorised EU health claim for arabinoxylan. In M. Sadler (Ed.), Foods, Nutrients and Food Ingredients with Authorised EU Health Claims (Vol. 3, pp. 201-218). United Kingdom: Elsevier. https://doi.org/10.1016/B978-0-08-100922-2.00013-9
Kellow, Nicole J. ; Walker, Karen Z. / Authorised EU health claim for arabinoxylan. Foods, Nutrients and Food Ingredients with Authorised EU Health Claims. editor / Michelle Sadler. Vol. 3 United Kingdom : Elsevier, 2018. pp. 201-218
@inbook{fe9c47a0f0944e37ad2adf29f28e4ad1,
title = "Authorised EU health claim for arabinoxylan",
abstract = "Arabinoxylans are hemicellulose dietary fibres abundant in the bran of many cereal grains including wheat and rice. They pass undigested through the human intestine until they reach the colon where they provide substrates for bacterial fermentation, generating beneficial short-chain fatty acids including acetate, butyrate and propionate. As viscous fibres, arabinoxylans help suppress appetite, delay gastric emptying and slow post-prandial glucose and insulin responses as well as promote laxation. Their beneficial effects on post-prandial glucose responses have been recognised by the European Food Safety Authority, and the European Union has authorised a health claim that 'consumption of arabinoxylan as part of a meal contributes to a reduction of the blood glucose rise after that meal'. Eight substantiating research trials are reviewed, four in healthy adults, three in people with metabolic disturbance and one in people with type 2 diabetes. Results indicate that arabinoxylans added to foods have particular utility for people with disturbed metabolic responses or type 2 diabetes to support improved cardiovascular health.",
keywords = "Arabinoxylans, Diabetes, Dietary fibre, Metabolic syndrome, Post-prandial glucose",
author = "Kellow, {Nicole J.} and Walker, {Karen Z.}",
year = "2018",
doi = "10.1016/B978-0-08-100922-2.00013-9",
language = "English",
isbn = "9780081009222",
volume = "3",
pages = "201--218",
editor = "Michelle Sadler",
booktitle = "Foods, Nutrients and Food Ingredients with Authorised EU Health Claims",
publisher = "Elsevier",
address = "Netherlands",

}

Kellow, NJ & Walker, KZ 2018, Authorised EU health claim for arabinoxylan. in M Sadler (ed.), Foods, Nutrients and Food Ingredients with Authorised EU Health Claims. vol. 3, Elsevier, United Kingdom, pp. 201-218. https://doi.org/10.1016/B978-0-08-100922-2.00013-9

Authorised EU health claim for arabinoxylan. / Kellow, Nicole J.; Walker, Karen Z.

Foods, Nutrients and Food Ingredients with Authorised EU Health Claims. ed. / Michelle Sadler. Vol. 3 United Kingdom : Elsevier, 2018. p. 201-218.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

TY - CHAP

T1 - Authorised EU health claim for arabinoxylan

AU - Kellow, Nicole J.

AU - Walker, Karen Z.

PY - 2018

Y1 - 2018

N2 - Arabinoxylans are hemicellulose dietary fibres abundant in the bran of many cereal grains including wheat and rice. They pass undigested through the human intestine until they reach the colon where they provide substrates for bacterial fermentation, generating beneficial short-chain fatty acids including acetate, butyrate and propionate. As viscous fibres, arabinoxylans help suppress appetite, delay gastric emptying and slow post-prandial glucose and insulin responses as well as promote laxation. Their beneficial effects on post-prandial glucose responses have been recognised by the European Food Safety Authority, and the European Union has authorised a health claim that 'consumption of arabinoxylan as part of a meal contributes to a reduction of the blood glucose rise after that meal'. Eight substantiating research trials are reviewed, four in healthy adults, three in people with metabolic disturbance and one in people with type 2 diabetes. Results indicate that arabinoxylans added to foods have particular utility for people with disturbed metabolic responses or type 2 diabetes to support improved cardiovascular health.

AB - Arabinoxylans are hemicellulose dietary fibres abundant in the bran of many cereal grains including wheat and rice. They pass undigested through the human intestine until they reach the colon where they provide substrates for bacterial fermentation, generating beneficial short-chain fatty acids including acetate, butyrate and propionate. As viscous fibres, arabinoxylans help suppress appetite, delay gastric emptying and slow post-prandial glucose and insulin responses as well as promote laxation. Their beneficial effects on post-prandial glucose responses have been recognised by the European Food Safety Authority, and the European Union has authorised a health claim that 'consumption of arabinoxylan as part of a meal contributes to a reduction of the blood glucose rise after that meal'. Eight substantiating research trials are reviewed, four in healthy adults, three in people with metabolic disturbance and one in people with type 2 diabetes. Results indicate that arabinoxylans added to foods have particular utility for people with disturbed metabolic responses or type 2 diabetes to support improved cardiovascular health.

KW - Arabinoxylans

KW - Diabetes

KW - Dietary fibre

KW - Metabolic syndrome

KW - Post-prandial glucose

UR - http://www.scopus.com/inward/record.url?scp=85041248355&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-100922-2.00013-9

DO - 10.1016/B978-0-08-100922-2.00013-9

M3 - Chapter (Book)

SN - 9780081009222

VL - 3

SP - 201

EP - 218

BT - Foods, Nutrients and Food Ingredients with Authorised EU Health Claims

A2 - Sadler, Michelle

PB - Elsevier

CY - United Kingdom

ER -

Kellow NJ, Walker KZ. Authorised EU health claim for arabinoxylan. In Sadler M, editor, Foods, Nutrients and Food Ingredients with Authorised EU Health Claims. Vol. 3. United Kingdom: Elsevier. 2018. p. 201-218 https://doi.org/10.1016/B978-0-08-100922-2.00013-9